Ist hydroxyresveratrol in der Schwangerschaft sicher?
No regulatory prohibition or harmonised CLP CMR classification was found for hydroxyresveratrol/oxyresveratrol (CAS 29700-22-9), and no published reproductive/developmental toxicity or human teratogenicity data specific to oxyresveratrol were identified in searches of PubMed and regulatory sources. PubChem and supplier datasheets identify the substance (synonym oxyresveratrol) and physicochemical properties (logP ≈3.2) consistent with some potential for dermal absorption, so topical use could give low but measurable systemic exposure in adults. Sources: PubChem; supplier/product pages; PubMed searches for reproductive data (no oxyresveratrol-specific repro studies found).
Pregnancy-safe products containing hydroxyresveratrol










Related ingredients
Frequently asked questions
- Ist hydroxyresveratrol in der Schwangerschaft sicher?
- No regulatory prohibition or harmonised CLP CMR classification was found for hydroxyresveratrol/oxyresveratrol (CAS 29700-22-9), and no published reproductive/developmental toxicity or human teratogenicity data specific to oxyresveratrol were identified in searches of PubMed and regulatory sources. PubChem and supplier datasheets identify the substance (synonym oxyresveratrol) and physicochemical properties (logP ≈3.2) consistent with some potential for dermal absorption, so topical use could give low but measurable systemic exposure in adults. Sources: PubChem; supplier/product pages; PubMed searches for reproductive data (no oxyresveratrol-specific repro studies found).
- Ist hydroxyresveratrol während des Stillens sicher?
- No evidence of harm to lactation or breastfeeding infants specific to oxyresveratrol was found. Because relevant human/animal lactation transfer data are lacking, and topical use can produce low systemic exposure, the conservative exposure score is low/measurable (e=1) but there is no mechanistic or reproductive evidence to raise hazard. Referenced supplier and chemical databases show identity and use in cosmetics; no CIR/SCCS/harmonised CLP classification was identified. (See sources.)
- Ist hydroxyresveratrol sicher für Babyhaut?
- No infant-specific safety or developmental skin studies were identified. Oxyresveratrol (INCI: hydroxyresveratrol) is used as a topical cosmetic active (skin-lightening/antioxidant). Given measurable dermal absorption in adults is plausible (logP ≈3.2) and immature infant skin increases per‑kg exposure, exposure for 0–3‑year skin is increased by one category vs adults (adult e=1 → baby e=2). There is no infant-specific hazard or mechanism data to increase h or m. Sources: supplier/COSmetic ingredient listings and PubChem. (No EU Annex II/III/banned/restricted listings found.)
- Wie bewertet VeriMom hydroxyresveratrol?
- VeriMom bewertet hydroxyresveratrol mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu hydroxyresveratrol?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu hydroxyresveratrol basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.